1-4 of 4
Jean-François Fléjou
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Characteristics and Clinical Impacts of the Immune Environments in Colorectal and Renal Cell Carcinoma Lung Metastases: Influence of Tumor Origin

Romain Remark, Marco Alifano, Isabelle Cremer, Audrey Lupo, Marie-Caroline Dieu-Nosjean, Marc Riquet, Lucile Crozet, Hanane Ouakrim, Jeremy Goc, Aurélie Cazes, Jean-François Fléjou, Laure Gibault, Virginie Verkarre, Jean-François Régnard, Olivier-Nicolas Pagès, Stéphane Oudard, Bernhard Mlecnik, Catherine Sautès-Fridman, Wolf-Herman Fridman, Diane Damotte
Journal: Clinical Cancer Research
Clin Cancer Res (2013) 19 (15): 4079–4091.
https://doi.org/10.1158/1078-0432.CCR-12-3847
Published: 31 July 2013
View articletitled, Characteristics and Clinical Impacts of the Immune Environments in Colorectal and Renal Cell Carcinoma Lung Metastases: Influence of Tumor Origin
Open the PDF for Characteristics and Clinical Impacts of the Immune Environments in Colorectal and Renal Cell Carcinoma Lung Metastases: Influence of Tumor Origin in another window
Includes: Supplementary data
Journal Articles

Defective Mismatch Repair Status as a Prognostic Biomarker of Disease-Free Survival in Stage III Colon Cancer Patients Treated with Adjuvant FOLFOX Chemotherapy

Aziz Zaanan, Jean-François Fléjou, Jean-François Emile, Guetz Gaëtan Des, Peggy Cuilliere-Dartigues, David Malka, Cédric Lecaille, Pierre Validire, Christophe Louvet, Philippe Rougier, Aimery de Gramont, Franck Bonnetain, Françoise Praz, Julien Taïeb
Journal: Clinical Cancer Research
Clin Cancer Res (2011) 17 (23): 7470–7478.
https://doi.org/10.1158/1078-0432.CCR-11-1048
Published: 30 November 2011
View articletitled, Defective Mismatch Repair Status as a Prognostic Biomarker of Disease-Free Survival in Stage III Colon Cancer Patients Treated with Adjuvant FOLFOX Chemotherapy
Open the PDF for Defective Mismatch Repair Status as a Prognostic Biomarker of Disease-Free Survival in Stage III Colon Cancer Patients Treated with Adjuvant FOLFOX Chemotherapy in another window
Includes: Supplementary data
Journal Articles

EGFR- and VEGF(R)-Targeted Small Molecules Show Synergistic Activity in Colorectal Cancer Models Refractory to Combinations of Monoclonal Antibodies

Virginie Poindessous, Djamila Ouaret, Karima El Ouadrani, Aude Battistella, Virginie F. Mégalophonos, Nyam Kamsu-Kom, Amélie Petitprez, Alexandre E. Escargueil, Pascaline Boudou, Sylvie Dumont, Pascale Cervera, Jean-François Fléjou, Thierry André, Christophe Tournigand, Benoist Chibaudel, Aimery de Gramont, Annette K. Larsen
Journal: Clinical Cancer Research
Clin Cancer Res (2011) 17 (20): 6522–6530.
https://doi.org/10.1158/1078-0432.CCR-11-1607
Published: 14 October 2011
View articletitled, EGFR- and VEGF(R)-Targeted Small Molecules Show Synergistic Activity in Colorectal Cancer Models Refractory to Combinations of Monoclonal Antibodies
Open the PDF for EGFR- and VEGF(R)-Targeted Small Molecules Show Synergistic Activity in Colorectal Cancer Models Refractory to Combinations of Monoclonal Antibodies in another window
Journal Articles

Preoperative Circulating Tumor Cell Detection Using the Isolation by Size of Epithelial Tumor Cell Method for Patients with Lung Cancer Is a New Prognostic Biomarker

Véronique Hofman, Christelle Bonnetaud, Marius I. Ilie, Philippe Vielh, Jean Michel Vignaud, Jean François Fléjou, Sylvie Lantuejoul, Eric Piaton, Nadine Mourad, Catherine Butori, Eric Selva, Michel Poudenx, Stéphanie Sibon, Sabrina Kelhef, Nicolas Vénissac, Jean-Philippe Jais, Jérôme Mouroux, Thierry Jo Molina, Paul Hofman
Journal: Clinical Cancer Research
Clin Cancer Res (2011) 17 (4): 827–835.
https://doi.org/10.1158/1078-0432.CCR-10-0445
Published: 15 February 2011
View articletitled, Preoperative Circulating Tumor Cell Detection Using the Isolation by Size of Epithelial Tumor Cell Method for Patients with Lung Cancer Is a New Prognostic Biomarker
Open the PDF for Preoperative Circulating Tumor Cell Detection Using the Isolation by Size of Epithelial Tumor Cell Method for Patients with Lung Cancer Is a New Prognostic Biomarker in another window
Includes: Supplementary data